A Boceprevir Failure in a Patient Infected with HCV Genotype 1G: Importance and Limitations of Virus Genotyping Prior to HCV Protease-Inhibitor-Based Therapy

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

2009 • 1,095 citations

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

2011 • 1,089 citations

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

2007 • 620 citations

Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection

2009 • 516 citations

Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

2007 • 383 citations

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients

2009 • 316 citations

Hepatitis C virus resistance to protease inhibitors

2011 • 297 citations

Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects

2008 • 213 citations

Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma

2007 • 145 citations

An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region

2011 • 133 citations

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice

2009 • 122 citations

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

2012 • 88 citations

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

2012 • 88 citations

Virological tools to diagnose and monitor hepatitis C virus infection

2010 • 77 citations

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

2011 • 55 citations

Specific Detection of Naturally Occurring Hepatitis C Virus Mutants with Resistance to Telaprevir and Boceprevir (Protease Inhibitors) among Treatment-Naïve Infected Individuals

2011 • 50 citations

Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial

2012 • 44 citations

Treatment failure with new hepatitis C drugs

2012 • 33 citations

Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses

2008 • 19 citations